Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A randomised trial comparing the safety and efficacy of the Zoladex 10.8-mg depot, administered every 12 weeks, to that of the Zoladex 3.6-mg depot, administered every 4 weeks, in patients with advanced prostate cancer. The Dutch South East Cooperative Urological Group.
Eur Urol. 1995;27(1):43-6. doi: 10.1159/000475122.
Eur Urol. 1995.
PMID: 7744141
Clinical Trial.
A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer.
Dijkman GA, del Moral PF, Plasman JW, Kums JJ, Delaere KP, Debruyne FM, Hutchinson FJ, Furr BJ.
Dijkman GA, et al. Among authors: plasman jw.
J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):933-6. doi: 10.1016/0960-0760(90)90446-r.
J Steroid Biochem Mol Biol. 1990.
PMID: 2149507
Item in Clipboard
A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depot.
Dijkman GA, Fernandez del Moral P, Plasman JW, Pull HC, van der Meijden AP, Debruyne FM, Hutchinson FG, Furr BJ.
Dijkman GA, et al. Among authors: plasman jw.
Eur Urol. 1990;18 Suppl 3:22-5. doi: 10.1159/000463974.
Eur Urol. 1990.
PMID: 2151271
Clinical Trial.
Item in Clipboard
A phase III randomized trial comparing the efficacy and safety of the 3-monthly 10.8-mg depot of Zoladex with the monthly 3.6-mg depot in patients with advanced prostate cancer. Dutch South East Cooperative Urological Group.
Dijkman GA, Debruyne FM, Fernandez del Moral P, Plasman JW, Hoefakker JW, Idema JG, Sykes M.
Dijkman GA, et al. Among authors: plasman jw.
Eur Urol. 1994;26 Suppl 1:1-2. doi: 10.1159/000475421.
Eur Urol. 1994.
PMID: 7737253
Clinical Trial.
No abstract available.
Item in Clipboard
A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer.
Debruyne FM, Dijkman GA, Lee DC, Witjes WP, del Moral F, Karthaus HF, van der Mejden AP, Plasman JW, Pull HC, Kums JJ, Idema JG, Hoefakker JW, Heijbroek RP, Kil PJ, Khoe GS.
Debruyne FM, et al. Among authors: plasman jw.
J Urol. 1996 Apr;155(4):1352-4.
J Urol. 1996.
PMID: 8632572
Free article.
Clinical Trial.
Item in Clipboard
Successful management of postoperative hemorrhage of the kidney by selective transcatheter embolization.
Debruyne FM, Boetes C, Plasman JW, Rosenbusch G, Chafik ML, Renders GA, Moonen WA.
Debruyne FM, et al. Among authors: plasman jw.
Arch Chir Neerl. 1978;30(4):217-22.
Arch Chir Neerl. 1978.
PMID: 736577
Item in Clipboard
Cite
Cite